Oobli Becomes First Company to Receive FDA "No Questions" Letter for a Novel Sweet Protein Produced via Precision Fermentation
DAVIS, Calif., March 20, 2024 /PRNewswire/ -- Oobli, the leading global sweet protein platform known for its healthy sugar alternatives, today announced it has received the "No questions" letter from the US Food & Drug Administration (FDA), accepting the Company's conclusion that the Oubli Fruit Sweet Protein (known by its scientific name as "brazzein") is Generally Recognized as Safe (GRAS) for use as a sweetener in food and beverages.
- "The Oubli Fruit Sweet Protein is one of several sweet proteins that is derived from fruits primarily found in West Africa and other equatorial environments.
- Oobli is the first company to receive the "No questions" letter from the FDA for use of the Oubli Fruit Sweet Protein as a food ingredient.
- "The Oubli Fruit Sweet Protein can be safely used in various foods with support from the general scientific community and the FDA.
- Oobli will sample its line of craft-brewed, low-sugar Sweet Teas, as well as its Dark and Milk Chocolates featuring the Oubli Fruit Sweet Protein, at the Future Food-Tech Conference in San Francisco from March 21-22.